SCHEMBL802037

SCHEMBL802037

Cc1ccc(NCc2ccccc2O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 1.00
HPGD P15428 2/20 0.68
CA12 O43570 2/20 0.61
CA2 P00918 2/20 0.61
CA9 Q16790 2/20 0.61
HIF1A Q16665 2/20 0.61
CA1 P00915 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HTT P42858 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
RAB9A P51151 2/20 0.58
ALDH1A1 P00352 2/20 0.57
APP P05067 1/20 0.56
HSD17B10 Q99714 3/20 0.54
GAA P10253 3/20 0.54
MAPK1 P28482 2/20 0.54
TP53 P04637 1/20 0.54
NOX4 Q9NPH5 2/20 0.54
EGFR P00533 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30301294 1.00 MAPT (1.00) MAPTHPGDCA12CA2CA9
SCHEMBL11593766 0.90 MAPT (0.81) MAPTHPGDCA12CA2CA9
SCHEMBL10781073 0.85 MAPT (0.73) MAPTHPGDCA12CA2CA9
SCHEMBL30208389 0.84 HIF1A (0.74) MAPTHPGDCA12CA2CA9
SCHEMBL802584 0.84 HIF1A (0.74) MAPTHPGDCA12CA2CA9
Hydrochloric Acid SCHEMBL11833104 0.82 HIF1A (0.72) MAPTHPGDCA12CA2CA9
SCHEMBL28911913 0.82 HIF1A (0.72) MAPTHPGDCA12CA2CA9
SCHEMBL6347332 0.82 MAPT (0.70) MAPTHPGDCA12CA2CA9
SCHEMBL11594145 0.81 MAPT (0.69) MAPTHPGDCA12CA2CA9
SCHEMBL10388262 0.81 HIF1A (0.71) MAPTHPGDCA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115745808-B Method for preparing secondary amine compound by catalyzing reduction of imine compound 延安大学 2024-04-30 CN disclosed
WO-2024005461-A1 NOVEL LINKER COMPOUND AND LIGAND-DRUG CONJUGATE THEREFOR 주식회사 트리오어 2024-01-04 WO disclosed
WO-2024005460-A1 COMPOUND COMPRISING SELF-IMMOLATIVE GROUP AND LIGAND-DRUG CONJUGATE COMPRISING SAME 주식회사 트리오어 2024-01-04 WO disclosed
CN-116574036-A Preparation method of C.I. active blue 49 chromophore 大连理工大学 2023-08-11 CN disclosed
CN-115745808-A Method for preparing secondary amine compound by catalyzing reduction of imine compound 延安大学 2023-03-07 CN disclosed
US-9126970-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-09-08 US disclosed
CN-101993382-B Aromatic amine derivative or analog and application thereof FUDAN UNIVERSITY (CN) 2014-10-29 CN disclosed
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-03-22 US disclosed
CN-101624382-B 2,3-diaryl-substituted-3,4-2H-1,3-benzoxazine with bactericidal and insecticidal activity UNIV HENAN SCIENCE & TECH 2011-04-27 CN disclosed
WO-2011047123-A2 ANAEROBICALLY CURABLE COMPOSITIONS HENKEL CORPORATION (US) 2011-04-21 WO disclosed
CN-102020592-A Urea carbamate methyl substituted arly ester with bactericidal activity UNIV HENAN SCIENCE & TECH 2011-04-20 CN disclosed
CN-101624382-A 2,3-diaryl-substituted-3,4-2H-1,3-benzoxazine with bactericidal and insecticidal activity UNIV HUNAN SCI & TECHNOLOGY 2010-01-13 CN disclosed
WO-2008156443-A1 BENZOXAZINE CONTAINING COMPOSITIONS OF MATTER AND CURABLE COMPOSITIONS MADE THEREWITH HENKEL CORPORATION (US) 2008-12-24 WO disclosed
CN-100341833-C Process for preparing aldehyde compounds INVISTA TECHNOLOGY CO LTD (US) 2007-10-10 CN disclosed
US-6960553-B2 Heat-sensitive recording material MITSUBISHI PAPER MILLS LTD. (JP) 2005-11-01 US disclosed
CN-1688531-A Process for preparing aldehyde compounds INVISTA TECHNOLOGY CO LTD (US) 2005-10-26 CN disclosed
US-20030186810-A1 Heat-sensitive recording material MITSUBISHI PAPER MILLS LTD. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068170-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SLCO2B1, SLCO1B3, SLCO4C1 MAPT 1399/4885HPGD 1041/4885CA12 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.